FGWP
GILD icon

Founders Grove Wealth Partners’s Gilead Sciences GILD Stock Holding History

Founders Grove Wealth Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$296K Buy
2,346
+219
+10% +$28.9K 0.06% 146
2026
Q1 		$296K Buy
2,127
+184
+9% +$25.8K 0.07% 129
2025
Q4 		$238K Buy
+1,943
New +$236K 0.05% 136

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Founders Grove Wealth Partners's GILD Position: Q2 2026 in Review

Founders Grove Wealth Partners increased its Gilead Sciences (GILD) stake by 10% in Q2 2026, buying an estimated $28.9K and bringing the position to 2,346 shares worth $296K. The position accounts for 0.06% of the portfolio, ranked #146.

Founders Grove Wealth Partners first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. The position peaked at $296K in Q1 2026. 610 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Founders Grove Wealth Partners held 2,346 shares of Gilead Sciences worth $296K as of Q2 2026.
  • Founders Grove Wealth Partners bought 219 Gilead Sciences shares in Q2 2026, an estimated $28.9K.
  • Gilead Sciences made up 0.06% of Founders Grove Wealth Partners's portfolio in Q2 2026, its #146 holding.
  • Founders Grove Wealth Partners first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • Founders Grove Wealth Partners's Gilead Sciences position peaked at $296K in Q1 2026.
  • 610 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Founders Grove Wealth Partners's 13F filing for Q2 2026, filed 22 Jul 2026.